| David A Harwood, MD | |
|
2 Worlds Fair Dr, Somerset, NJ 08873-1369 | |
| (732) 537-0909 | |
| (732) 564-9032 |
| Full Name | David A Harwood |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 40 Years |
| Location | 2 Worlds Fair Dr, Somerset, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144225079 | NPI | - | NPPES |
| MA47824 | Other | NJ | LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Redeemer Home Care Nj North | Elizabeth, NJ | Home health agency |
| Vna Of Central Jersey Home Care & Hospice | Toms river, NJ | Home health agency |
| Saint Peter's University Hospital | New brunswick, NJ | Hospital |
| Raritan Bay Medical Center Perth Amboy Division | Perth amboy, NJ | Hospital |
| Berkshire Medical Center | Pittsfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthonj Llc | 6800225178 | 276 |
News Archive
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.
Researchers with The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have identified a metabolic process in the heart that, if treated, could someday prevent or slow the progression of heart failure.
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
› Verified 6 days ago
| Entity Name | University Orthopaedic Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962691527 PECOS PAC ID: 9830256577 Enrollment ID: O20090324000373 |
News Archive
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.
Researchers with The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have identified a metabolic process in the heart that, if treated, could someday prevent or slow the progression of heart failure.
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
› Verified 6 days ago
| Entity Name | Orthonj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720557432 PECOS PAC ID: 6800225178 Enrollment ID: O20200408000333 |
News Archive
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.
Researchers with The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have identified a metabolic process in the heart that, if treated, could someday prevent or slow the progression of heart failure.
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Harwood, MD 2 Worlds Fair Dr, Somerset, NJ 08873-1369 Ph: (732) 537-0909 | David A Harwood, MD 2 Worlds Fair Dr, Somerset, NJ 08873-1369 Ph: (732) 537-0909 |
News Archive
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries.
Researchers with The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have identified a metabolic process in the heart that, if treated, could someday prevent or slow the progression of heart failure.
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
› Verified 6 days ago
Mark S Butler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-537-0909 Fax: 732-564-9032 | |
Dr. Stephen S. Cook, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-979-2115 Fax: 732-564-9032 | |
Gino Chiappetta, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-537-0909 Fax: 732-564-9032 | |
Dr. Michael P. Coyle Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-979-2115 Fax: 732-564-9032 | |
James Taylor Monica, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-537-0909 Fax: 732-564-9032 | |
Dr. Carlos Alberto Sagebien, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Worlds Fair Dr, Somerset, NJ 08873 Phone: 732-537-0909 Fax: 732-564-9032 |